Cationization of a monoclonal antibody to the human immunodeficiency virus REV protein enhances cellular uptake but does not impair antigen binding of the antibody
- 1 October 1994
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 42 (3) , 191-195
- https://doi.org/10.1016/0165-2478(94)90085-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Development and in vitro Characterization of a Cationized Monoclonal Antibody against βA4 Protein: A Potential Probe for Alzheimer's DiseaseBioconjugate Chemistry, 1994
- Enhanced Endocytosis and Anti-Human Immunodeficiency Virus Type 1 Activity of Anti-rev Antibodies after CationizationThe Journal of Infectious Diseases, 1994
- Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.Proceedings of the National Academy of Sciences, 1993
- Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs.Genes & Development, 1991
- Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element.Proceedings of the National Academy of Sciences, 1991
- Capillary Depletion Method for Quantification of Blood–Brain Barrier Transport of Circulating Peptides and Plasma ProteinsJournal of Neurochemistry, 1990
- Monoclonal antibodies directed against the rev protein of human immunodeficiency virus type 1Molecular and Cellular Probes, 1990
- Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein.Proceedings of the National Academy of Sciences, 1989
- Cationic antigens: Problems associated with measurement by ELISAJournal of Immunological Methods, 1986
- Conjugation of poly-L-lysine to albumin and horseradish peroxidase: a novel method of enhancing the cellular uptake of proteins.Proceedings of the National Academy of Sciences, 1978